These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15500953)

  • 1. Serum levels of angiogenic cytokines decrease after antineoplastic radiotherapy.
    Ria R; Portaluri M; Russo F; Cirulli T; Di Pietro G; Bambace S; Cucci F; Romano T; Vacca A; Dammacco F
    Cancer Lett; 2004 Dec; 216(1):103-7. PubMed ID: 15500953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
    Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
    Bremnes RM; Camps C; Sirera R
    Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased growth factor expression after hepatic and pancreatic resection.
    Justinger C; Schlüter C; Oliviera-Frick V; Kopp B; Rubie C; Schilling MK
    Oncol Rep; 2008 Dec; 20(6):1527-31. PubMed ID: 19020737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure.
    Lamblin N; Susen S; Dagorn J; Mouquet F; Jude B; Van Belle E; Bauters C; de Groote P
    Am Heart J; 2005 Jul; 150(1):137-43. PubMed ID: 16084160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure.
    Aw MM; Mitry RR; Hughes RD; Dhawan A
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):224-7. PubMed ID: 17255836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of endostatin, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy.
    Seko Y; Fukuda S; Nagai R
    Clin Sci (Lond); 2004 May; 106(5):439-42. PubMed ID: 14965340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgery.
    Curigliano G; Petit JY; Bertolini F; Colleoni M; Peruzzotti G; de Braud F; Gandini S; Giraldo A; Martella S; Orlando L; Munzone E; Pietri E; Luini A; Goldhirsch A
    Breast Cancer Res Treat; 2005 Sep; 93(1):35-40. PubMed ID: 16184456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization.
    Susen S; Sautière K; Mouquet F; Cuilleret F; Chmaït A; McFadden EP; Hennache B; Richard F; de Groote P; Lablanche JM; Dallongeville J; Bauters C; Jude B; Van Belle E
    Eur Heart J; 2005 Nov; 26(22):2387-95. PubMed ID: 16105849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
    Alexandrakis MG; Sfiridaki A; Miyakis S; Pappa C; Kandidaki E; Alegakis A; Margioris AN
    Clin Chim Acta; 2007 Apr; 379(1-2):31-5. PubMed ID: 17234170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of circulating angiogenic factors in patients operated on for localized malignant melanoma.
    Bolander A; Wagenius G; Larsson A; Brattström D; Ullenhag G; Hesselius P; Ekman S; Bergqvist M
    Anticancer Res; 2007; 27(5A):3211-7. PubMed ID: 17970063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and other markers for prediction of survival in metastatic renal cell carcinoma.
    Alamdari FI; Rasmuson T; Grankvist K; Ljungberg B
    Scand J Urol Nephrol; 2007; 41(1):5-9. PubMed ID: 17366095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of hepatocyte growth factor/scatter factor (HGF/SF) on fibroblast growth factor-2 (FGF-2) levels in external auditory canal cholesteatoma (EACC) cell culture.
    Naim R; Chang RC; Sadick H; Hormann K
    In Vivo; 2005; 19(3):599-603. PubMed ID: 15875782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
    Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
    Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival.
    Andersen NF; Standal T; Nielsen JL; Heickendorff L; Borset M; Sørensen FB; Abildgaard N
    Br J Haematol; 2005 Jan; 128(2):210-7. PubMed ID: 15638855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study.
    McMeekin DS; Sill MW; Darcy KM; Stearns-Kurosawa DJ; Webster K; Waggoner S; Benbrook D
    Gynecol Oncol; 2007 Sep; 106(3):596-603. PubMed ID: 17597196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum vascular endothelial growth factor as a predictive factor in metronomic (weekly) Paclitaxel treatment for advanced head and neck cancer.
    Caballero M; Grau JJ; Blanch JL; Domingo-Domenech J; Auge JM; Jimenez W; Bernal-Sprekelsen M
    Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1143-8. PubMed ID: 18025320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response.
    Pour L; Svachova H; Adam Z; Almasi M; Buresova L; Buchler T; Kovarova L; Nemec P; Penka M; Vorlicek J; Hajek R
    Ann Hematol; 2010 Apr; 89(4):385-9. PubMed ID: 19784651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.